0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Vaccines Market Insights and Forecast to 2027
Published Date: May 2021
|
Report Code: QYRE-Othe-3142
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global Vaccines Market Insights and Forecast to 2027

Global Vaccines Market Insights and Forecast to 2027

Code: QYRE-Othe-3142
Report
May 2021
119 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type

Recombinant Vaccines
Viral Vaccines
Polysaccharide Vaccines
Others

Segment by Application

Cholera
Hepatitis B
Diphtheria
Tetanus
Measles Vaccine
Hepatitis A
Live Attenuated Influenza Vaccine
Polio Vaccine
Rabies Vaccine

BY COMPANY

GSK
Sanofi
Merck
Pfizer
Novartis(GSK)
CSL
MedImmune LLC
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
Jintan

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
1 Study Coverage
1.1 Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Vaccines Market Size Growth Rate by Type
1.4.2 Recombinant Vaccines
1.4.3 Viral Vaccines
1.2.4 Polysaccharide Vaccines
1.2.5 Others
1.3 Market by Application
1.3.1 Global Vaccines Market Size Growth Rate by Application
1.3.2 Cholera
1.3.3 Hepatitis B
1.3.4 Diphtheria
1.3.5 Tetanus
1.3.6 Measles Vaccine
1.3.7 Hepatitis A
1.3.8 Live Attenuated Influenza Vaccine
1.3.9 Polio Vaccine
1.3.10 Rabies Vaccine
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Vaccines Sales Estimates and Forecasts 2016-2027
2.2 Global Vaccines Revenue Estimates and Forecasts 2016-2027
2.3 Global Vaccines Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Vaccines Regions by Sales
2.4.1 Global Top Vaccines Regions by Sales (2016-2021)
2.4.2 Global Top Vaccines Regions by Sales (2022-2027)
2.5 Global Top Vaccines Regions by Revenue
2.5.1 Global Top Vaccines Regions by Revenue (2016-2021)
2.5.2 Global Top Vaccines Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Vaccines Sales by Manufacturers
3.1.1 Global Top Vaccines Manufacturers by Sales (2016-2021)
3.1.2 Global Top Vaccines Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Vaccines Sales in 2020
3.2 Global Vaccines Revenue by Manufacturers
3.2.1 Global Top Vaccines Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Vaccines Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Vaccines Revenue in 2020
3.3 Global Vaccines Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Vaccines Sales by Type
4.1.1 Global Vaccines Historical Sales by Type (2016-2021)
4.1.2 Global Vaccines Forecasted Sales by Type (2022-2027)
4.1.3 Global Vaccines Sales Market Share by Type (2016-2027)
4.2 Global Vaccines Revenue by Type
4.2.1 Global Vaccines Historical Revenue by Type (2016-2021)
4.2.2 Global Vaccines Forecasted Revenue by Type (2022-2027)
4.2.3 Global Vaccines Revenue Market Share by Type (2016-2027)
4.3 Global Vaccines Price by Type
4.3.1 Global Vaccines Price by Type (2016-2021)
4.3.2 Global Vaccines Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Vaccines Sales by Application
5.1.1 Global Vaccines Historical Sales by Application (2016-2021)
5.1.2 Global Vaccines Forecasted Sales by Application (2022-2027)
5.1.3 Global Vaccines Sales Market Share by Application (2016-2027)
5.2 Global Vaccines Revenue by Application
5.2.1 Global Vaccines Historical Revenue by Application (2016-2021)
5.2.2 Global Vaccines Forecasted Revenue by Application (2022-2027)
5.2.3 Global Vaccines Revenue Market Share by Application (2016-2027)
5.3 Global Vaccines Price by Application
5.3.1 Global Vaccines Price by Application (2016-2021)
5.3.2 Global Vaccines Price Forecast by Application (2022-2027)
6 North America
6.1 North America Vaccines Market Size by Type
6.1.1 North America Vaccines Sales by Type (2016-2027)
6.1.2 North America Vaccines Revenue by Type (2016-2027)
6.2 North America Vaccines Market Size by Application
6.2.1 North America Vaccines Sales by Application (2016-2027)
6.2.2 North America Vaccines Revenue by Application (2016-2027)
6.3 North America Vaccines Market Size by Country
6.3.1 North America Vaccines Sales by Country (2016-2027)
6.3.2 North America Vaccines Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Vaccines Market Size by Type
7.1.1 Europe Vaccines Sales by Type (2017-2027)
7.1.2 Europe Vaccines Revenue by Type (2017-2027)
7.2 Europe Vaccines Market Size by Application
7.2.1 Europe Vaccines Sales by Application (2017-2027)
7.2.2 Europe Vaccines Revenue by Application (2017-2027)
7.3 Europe Vaccines Market Size by Country
7.3.1 Europe Vaccines Sales by Country (2017-2027)
7.3.2 Europe Vaccines Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Vaccines Market Size by Type
8.1.1 Asia Pacific Vaccines Sales by Type (2018-2027)
8.1.2 Asia Pacific Vaccines Revenue by Type (2018-2027)
8.2 Asia Pacific Vaccines Market Size by Application
8.2.1 Asia Pacific Vaccines Sales by Application (2018-2027)
8.2.2 Asia Pacific Vaccines Revenue by Application (2018-2027)
8.3 Asia Pacific Vaccines Market Size by Region
8.3.1 Asia Pacific Vaccines Sales by Region (2018-2027)
8.3.2 Asia Pacific Vaccines Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Vaccines Market Size by Type
9.1.1 Latin America Vaccines Sales by Type (2019-2027)
9.1.2 Latin America Vaccines Revenue by Type (2019-2027)
9.2 Latin America Vaccines Market Size by Application
9.2.1 Latin America Vaccines Sales by Application (2019-2027)
9.2.2 Latin America Vaccines Revenue by Application (2019-2027)
9.3 Latin America Vaccines Market Size by Country
9.3.1 Latin America Vaccines Sales by Country (2019-2027)
9.3.2 Latin America Vaccines Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Vaccines Market Size by Type
6.1.1 Middle East and Africa Vaccines Sales by Type (2016-2027)
6.1.2 Middle East and Africa Vaccines Revenue by Type (2016-2027)
6.2 Middle East and Africa Vaccines Market Size by Application
6.2.1 Middle East and Africa Vaccines Sales by Application (2016-2027)
6.2.2 Middle East and Africa Vaccines Revenue by Application (2016-2027)
6.3 Middle East and Africa Vaccines Market Size by Country
6.3.1 Middle East and Africa Vaccines Sales by Country (2016-2027)
6.3.2 Middle East and Africa Vaccines Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Overview
11.1.3 GSK Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 GSK Vaccines Product Description
11.1.5 GSK Related Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Overview
11.2.3 Sanofi Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Sanofi Vaccines Product Description
11.2.5 Sanofi Related Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Overview
11.3.3 Merck Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Merck Vaccines Product Description
11.3.5 Merck Related Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Pfizer Vaccines Product Description
11.4.5 Pfizer Related Developments
11.5 Novartis(GSK)
11.5.1 Novartis(GSK) Corporation Information
11.5.2 Novartis(GSK) Overview
11.5.3 Novartis(GSK) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Novartis(GSK) Vaccines Product Description
11.5.5 Novartis(GSK) Related Developments
11.6 CSL
11.6.1 CSL Corporation Information
11.6.2 CSL Overview
11.6.3 CSL Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 CSL Vaccines Product Description
11.6.5 CSL Related Developments
11.7 MedImmune LLC
11.7.1 MedImmune LLC Corporation Information
11.7.2 MedImmune LLC Overview
11.7.3 MedImmune LLC Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 MedImmune LLC Vaccines Product Description
11.7.5 MedImmune LLC Related Developments
11.8 J&J(Crucell)
11.8.1 J&J(Crucell) Corporation Information
11.8.2 J&J(Crucell) Overview
11.8.3 J&J(Crucell) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 J&J(Crucell) Vaccines Product Description
11.8.5 J&J(Crucell) Related Developments
11.9 China National Biotec
11.9.1 China National Biotec Corporation Information
11.9.2 China National Biotec Overview
11.9.3 China National Biotec Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 China National Biotec Vaccines Product Description
11.9.5 China National Biotec Related Developments
11.10 Tiantan
11.10.1 Tiantan Corporation Information
11.10.2 Tiantan Overview
11.10.3 Tiantan Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Tiantan Vaccines Product Description
11.10.5 Tiantan Related Developments
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Overview
11.1.3 GSK Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 GSK Vaccines Product Description
11.1.5 GSK Related Developments
11.12 Kangtai
11.12.1 Kangtai Corporation Information
11.12.2 Kangtai Overview
11.12.3 Kangtai Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Kangtai Product Description
11.12.5 Kangtai Related Developments
11.13 Hissen
11.13.1 Hissen Corporation Information
11.13.2 Hissen Overview
11.13.3 Hissen Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 Hissen Product Description
11.13.5 Hissen Related Developments
11.14 Jintan
11.14.1 Jintan Corporation Information
11.14.2 Jintan Overview
11.14.3 Jintan Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.14.4 Jintan Product Description
11.14.5 Jintan Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Vaccines Value Chain Analysis
12.2 Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vaccines Production Mode & Process
12.4 Vaccines Sales and Marketing
12.4.1 Vaccines Sales Channels
12.4.2 Vaccines Distributors
12.5 Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Vaccines Industry Trends
13.2 Vaccines Market Drivers
13.3 Vaccines Market Challenges
13.4 Vaccines Market Restraints
14 Key Findings in The Global Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Vaccines Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Recombinant Vaccines
    Table 3. Major Manufacturers of Viral Vaccines
    Table 4. Major Manufacturers of Polysaccharide Vaccines
    Table 5. Major Manufacturers of Others
    Table 6. Global Vaccines Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
    Table 7. Global Vaccines Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
    Table 8. Global Vaccines Sales by Region (2016-2021) & (K Pcs)
    Table 9. Global Vaccines Sales Market Share by Region (2016-2021)
    Table 10. Global Vaccines Sales by Region (2016-2021) & (K Pcs)
    Table 11. Global Vaccines Sales Market Share by Region (2022-2027)
    Table 12. Global Vaccines Revenue by Region (2016-2021) & (US$ Million)
    Table 13. Global Vaccines Revenue Market Share by Region (2016-2021)
    Table 14. Global Vaccines Revenue by Region (2022-2027) & (US$ Million)
    Table 15. Global Vaccines Revenue Market Share by Region (2022-2027)
    Table 16. Global Vaccines Sales by Manufacturers (2016-2021) & (K Pcs)
    Table 17. Global Vaccines Sales Share by Manufacturers (2016-2021)
    Table 18. Global Vaccines Revenue by Manufacturers (2016-2021) & (US$ Million)
    Table 19. Global Vaccines Revenue Share by Manufacturers (2016-2021)
    Table 20. Vaccines Price by Manufacturers 2016-2021 (USD/Pcs)
    Table 21. Global Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccines as of 2020)
    Table 23. Vaccines Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Vaccines Product Offered
    Table 25. Date of Manufacturers Enter into Vaccines Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Vaccines Sales by Type (2016-2021) & (K Pcs)
    Table 28. Global Vaccines Sales by Type (2022-2027) & (K Pcs)
    Table 29. Global Vaccines Sales Share by Type (2016-2021)
    Table 30. Global Vaccines Sales Share by Type (2022-2027)
    Table 31. Global Vaccines Revenue by Type (2016-2021) & (US$ Million)
    Table 32. Global Vaccines Revenue by Type (2022-2027) & (US$ Million)
    Table 33. Global Vaccines Revenue Share by Type (2016-2021)
    Table 34. Global Vaccines Revenue Share by Type (2022-2027)
    Table 35. Vaccines Price by Type (2016-2021) & (USD/Pcs)
    Table 36. Global Vaccines Price Forecast by Type (2022-2027) & (USD/Pcs)
    Table 37. Global Vaccines Sales by Application (2016-2021) & (K Pcs)
    Table 38. Global Vaccines Sales by Application (2022-2027) & (K Pcs)
    Table 39. Global Vaccines Sales Share by Application (2016-2021)
    Table 40. Global Vaccines Sales Share by Application (2022-2027)
    Table 41. Global Vaccines Revenue by Application (2016-2021) & (US$ Million)
    Table 42. Global Vaccines Revenue by Application (2022-2027) & (US$ Million)
    Table 43. Global Vaccines Revenue Share by Application (2016-2021)
    Table 44. Global Vaccines Revenue Share by Application (2022-2027)
    Table 45. Vaccines Price by Application (2016-2021) & (USD/Pcs)
    Table 46. Global Vaccines Price Forecast by Application (2022-2027) & (USD/Pcs)
    Table 47. North America Vaccines Sales by Type (2016-2021) & (K Pcs)
    Table 48. North America Vaccines Sales by Type (2022-2027) & (K Pcs)
    Table 49. North America Vaccines Revenue by Type (2016-2021) & (US$ Million)
    Table 50. North America Vaccines Revenue by Type (2022-2027) & (US$ Million)
    Table 51. North America Vaccines Sales by Application (2016-2021) & (K Pcs)
    Table 52. North America Vaccines Sales by Application (2022-2027) & (K Pcs)
    Table 53. North America Vaccines Revenue by Application (2016-2021) & (US$ Million)
    Table 54. North America Vaccines Revenue by Application (2022-2027) & (US$ Million)
    Table 55. North America Vaccines Sales by Country (2016-2021) & (K Pcs)
    Table 56. North America Vaccines Sales by Country (2022-2027) & (K Pcs)
    Table 57. North America Vaccines Revenue by Country (2016-2021) & (US$ Million)
    Table 58. North America Vaccines Revenue by Country (2022-2027) & (US$ Million)
    Table 59. Europe Vaccines Sales by Type (2016-2021) & (K Pcs)
    Table 60. Europe Vaccines Sales by Type (2022-2027) & (K Pcs)
    Table 61. Europe Vaccines Revenue by Type (2016-2021) & (US$ Million)
    Table 62. Europe Vaccines Revenue by Type (2022-2027) & (US$ Million)
    Table 63. Europe Vaccines Sales by Application (2016-2021) & (K Pcs)
    Table 64. Europe Vaccines Sales by Application (2022-2027) & (K Pcs)
    Table 65. Europe Vaccines Revenue by Application (2016-2021) & (US$ Million)
    Table 66. Europe Vaccines Revenue by Application (2022-2027) & (US$ Million)
    Table 67. Europe Vaccines Sales by Country (2016-2021) & (K Pcs)
    Table 68. Europe Vaccines Sales by Country (2022-2027) & (K Pcs)
    Table 69. Europe Vaccines Revenue by Country (2016-2021) & (US$ Million)
    Table 70. Europe Vaccines Revenue by Country (2022-2027) & (US$ Million)
    Table 71. Asia Pacific Vaccines Sales by Type (2016-2021) & (K Pcs)
    Table 72. Asia Pacific Vaccines Sales by Type (2022-2027) & (K Pcs)
    Table 73. Asia Pacific Vaccines Revenue by Type (2016-2021) & (US$ Million)
    Table 74. Asia Pacific Vaccines Revenue by Type (2022-2027) & (US$ Million)
    Table 75. Asia Pacific Vaccines Sales by Application (2016-2021) & (K Pcs)
    Table 76. Asia Pacific Vaccines Sales by Application (2022-2027) & (K Pcs)
    Table 77. Asia Pacific Vaccines Revenue by Application (2016-2021) & (US$ Million)
    Table 78. Asia Pacific Vaccines Revenue by Application (2022-2027) & (US$ Million)
    Table 79. Asia Pacific Vaccines Sales by Region (2016-2021) & (K Pcs)
    Table 80. Asia Pacific Vaccines Sales by Region (2022-2027) & (K Pcs)
    Table 81. Asia Pacific Vaccines Revenue by Region (2016-2021) & (US$ Million)
    Table 82. Asia Pacific Vaccines Revenue by Region (2022-2027) & (US$ Million)
    Table 83. Latin America Vaccines Sales by Type (2016-2021) & (K Pcs)
    Table 84. Latin America Vaccines Sales by Type (2022-2027) & (K Pcs)
    Table 85. Latin America Vaccines Revenue by Type (2016-2021) & (US$ Million)
    Table 86. Latin America Vaccines Revenue by Type (2022-2027) & (US$ Million)
    Table 87. Latin America Vaccines Sales by Application (2016-2021) & (K Pcs)
    Table 88. Latin America Vaccines Sales by Application (2022-2027) & (K Pcs)
    Table 89. Latin America Vaccines Revenue by Application (2016-2021) & (US$ Million)
    Table 90. Latin America Vaccines Revenue by Application (2022-2027) & (US$ Million)
    Table 91. Latin America Vaccines Sales by Country (2016-2021) & (K Pcs)
    Table 92. Latin America Vaccines Sales by Country (2022-2027) & (K Pcs)
    Table 93. Latin America Vaccines Revenue by Country (2016-2021) & (US$ Million)
    Table 94. Latin America Vaccines Revenue by Country (2022-2027) & (US$ Million)
    Table 95. Middle East and Africa Vaccines Sales by Type (2016-2021) & (K Pcs)
    Table 96. Middle East and Africa Vaccines Sales by Type (2022-2027) & (K Pcs)
    Table 97. Middle East and Africa Vaccines Revenue by Type (2016-2021) & (US$ Million)
    Table 98. Middle East and Africa Vaccines Revenue by Type (2022-2027) & (US$ Million)
    Table 99. Middle East and Africa Vaccines Sales by Application (2016-2021) & (K Pcs)
    Table 100. Middle East and Africa Vaccines Sales by Application (2022-2027) & (K Pcs)
    Table 101. Middle East and Africa Vaccines Revenue by Application (2016-2021) & (US$ Million)
    Table 102. Middle East and Africa Vaccines Revenue by Application (2022-2027) & (US$ Million)
    Table 103. Middle East and Africa Vaccines Sales by Country (2016-2021) & (K Pcs)
    Table 104. Middle East and Africa Vaccines Sales by Country (2022-2027) & (K Pcs)
    Table 105. Middle East and Africa Vaccines Revenue by Country (2016-2021) & (US$ Million)
    Table 106. Middle East and Africa Vaccines Revenue by Country (2022-2027) & (US$ Million)
    Table 107. GSK Corporation Information
    Table 108. GSK Description and Major Businesses
    Table 109. GSK Vaccines Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 110. GSK Vaccines Product
    Table 111. GSK Recent Developments
    Table 112. Sanofi Corporation Information
    Table 113. Sanofi Description and Major Businesses
    Table 114. Sanofi Vaccines Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 115. Sanofi Vaccines Product
    Table 116. Sanofi Recent Developments
    Table 117. Merck Corporation Information
    Table 118. Merck Description and Major Businesses
    Table 119. Merck Vaccines Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 120. Merck Vaccines Product
    Table 121. Merck Recent Developments
    Table 122. Pfizer Corporation Information
    Table 123. Pfizer Description and Major Businesses
    Table 124. Pfizer Vaccines Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 125. Pfizer Vaccines Product
    Table 126. Pfizer Recent Developments
    Table 127. Novartis(GSK) Corporation Information
    Table 128. Novartis(GSK) Description and Major Businesses
    Table 129. Novartis(GSK) Vaccines Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 130. Novartis(GSK) Vaccines Product
    Table 131. Novartis(GSK) Recent Developments
    Table 132. CSL Corporation Information
    Table 133. CSL Description and Major Businesses
    Table 134. CSL Vaccines Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 135. CSL Vaccines Product
    Table 136. CSL Recent Developments
    Table 137. MedImmune LLC Corporation Information
    Table 138. MedImmune LLC Description and Major Businesses
    Table 139. MedImmune LLC Vaccines Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 140. MedImmune LLC Vaccines Product
    Table 141. MedImmune LLC Recent Developments
    Table 142. J&J(Crucell) Corporation Information
    Table 143. J&J(Crucell) Description and Major Businesses
    Table 144. J&J(Crucell) Vaccines Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 145. J&J(Crucell) Vaccines Product
    Table 146. J&J(Crucell) Recent Developments
    Table 147. China National Biotec Corporation Information
    Table 148. China National Biotec Description and Major Businesses
    Table 149. China National Biotec Vaccines Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 150. China National Biotec Vaccines Product
    Table 151. China National Biotec Recent Developments
    Table 152. Tiantan Corporation Information
    Table 153. Tiantan Description and Major Businesses
    Table 154. Tiantan Vaccines Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 155. Tiantan Vaccines Product
    Table 156. Tiantan Recent Developments
    Table 157. Hualan Corporation Information
    Table 158. Hualan Description and Major Businesses
    Table 159. Hualan Vaccines Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 160. Hualan Vaccines Product
    Table 161. Hualan Recent Developments
    Table 162. Kangtai Corporation Information
    Table 163. Kangtai Description and Major Businesses
    Table 164. Kangtai Vaccines Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 165. Kangtai Vaccines Product
    Table 166. Kangtai Recent Developments
    Table 167. Hissen Corporation Information
    Table 168. Hissen Description and Major Businesses
    Table 169. Hissen Vaccines Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 170. Hissen Vaccines Product
    Table 171. Hissen Recent Developments
    Table 172. Jintan Corporation Information
    Table 173. Jintan Description and Major Businesses
    Table 174. Jintan Vaccines Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 175. Jintan Vaccines Product
    Table 176. Jintan Recent Developments
    Table 177. Key Raw Materials Lists
    Table 178. Raw Materials Key Suppliers Lists
    Table 179. Vaccines Distributors List
    Table 180. Vaccines Customers List
    Table 181. Vaccines Market Trends
    Table 182. Vaccines Market Drivers
    Table 183. Vaccines Market Challenges
    Table 184. Vaccines Market Restraints
    Table 185. Research Programs/Design for This Report
    Table 186. Key Data Information from Secondary Sources
    Table 187. Key Data Information from Primary Sources
List of Figures
    Figure 1. Vaccines Product Picture
    Figure 2. Global Vaccines Market Share by Type in 2020 & 2027
    Figure 3. Recombinant Vaccines Product Picture
    Figure 4. Viral Vaccines Product Picture
    Figure 5. Polysaccharide Vaccines Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Vaccines Sales Market Share by Application in 2020 & 2027
    Figure 8. Cholera
    Figure 9. Hepatitis B
    Figure 10. Diphtheria
    Figure 11. Tetanus
    Figure 12. Measles Vaccine
    Figure 13. Hepatitis A
    Figure 14. Live Attenuated Influenza Vaccine
    Figure 15. Polio Vaccine
    Figure 16. Rabies Vaccine
    Figure 17. Vaccines Report Years Considered
    Figure 18. Global Vaccines Sales 2016-2027 (K Pcs)
    Figure 19. Global Vaccines Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 20. Global Vaccines Revenue 2016-2027 (US$ Million)
    Figure 21. Global Vaccines Revenue Market Share by Region in Percentage: 2020 Versus 2027
    Figure 22. Global Vaccines Sales Market Share by Region (2016-2021)
    Figure 23. Global Vaccines Sales Market Share by Region (2022-2027)
    Figure 24. North America Vaccines Sales YoY (2016-2027) & (K Pcs)
    Figure 25. North America Vaccines Revenue YoY (2016-2027) & (US$ Million)
    Figure 26. Europe Vaccines Sales YoY (2016-2027) & (K Pcs)
    Figure 27. Europe Vaccines Revenue YoY (2016-2027) & (US$ Million)
    Figure 28. Asia-Pacific Vaccines Sales YoY (2016-2027) & (K Pcs)
    Figure 29. Asia-Pacific Vaccines Revenue YoY (2016-2027) & (US$ Million)
    Figure 30. Latin America Vaccines Sales YoY (2016-2027) & (K Pcs)
    Figure 31. Latin America Vaccines Revenue YoY (2016-2027) & (US$ Million)
    Figure 32. Middle East & Africa Vaccines Sales YoY (2016-2027) & (K Pcs)
    Figure 33. Middle East & Africa Vaccines Revenue YoY (2016-2027) & (US$ Million)
    Figure 34. The Top 10 and Top 5 Players Market Share by Vaccines Sales in 2020
    Figure 35. The Top 10 and Top 5 Players Market Share by Vaccines Revenue in 2020
    Figure 36. Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
    Figure 37. Global Vaccines Sales Market Share by Type (2016-2027)
    Figure 38. Global Vaccines Revenue Market Share by Type (2016-2027)
    Figure 39. Global Vaccines Sales Market Share by Application (2016-2027)
    Figure 40. Global Vaccines Revenue Market Share by Application (2016-2027)
    Figure 41. North America Vaccines Sales Market Share by Type (2016-2027)
    Figure 42. North America Vaccines Revenue Market Share by Type (2016-2027)
    Figure 43. North America Vaccines Sales Market Share by Application (2016-2027)
    Figure 44. North America Vaccines Revenue Market Share by Application (2016-2027)
    Figure 45. North America Vaccines Sales Share by Country (2016-2027)
    Figure 46. North America Vaccines Revenue Share by Country (2016-2027)
    Figure 47. U.S. Vaccines Revenue (2016-2027) & (US$ Million)
    Figure 48. Canada Vaccines Revenue (2016-2027) & (US$ Million)
    Figure 49. Europe Vaccines Sales Market Share by Type (2016-2027)
    Figure 50. Europe Vaccines Revenue Market Share by Type (2016-2027)
    Figure 51. Europe Vaccines Sales Market Share by Application (2016-2027)
    Figure 52. Europe Vaccines Revenue Market Share by Application (2016-2027)
    Figure 53. Europe Vaccines Sales Share by Country (2016-2027)
    Figure 54. Europe Vaccines Revenue Share by Country (2016-2027)
    Figure 55. Germany Vaccines Revenue (2016-2027) & (US$ Million)
    Figure 56. France Vaccines Revenue (2016-2027) & (US$ Million)
    Figure 57. U.K. Vaccines Revenue (2016-2027) & (US$ Million)
    Figure 58. Italy Vaccines Revenue (2016-2027) & (US$ Million)
    Figure 59. Russia Vaccines Revenue (2016-2027) & (US$ Million)
    Figure 60. Asia Pacific Vaccines Sales Market Share by Type (2016-2027)
    Figure 61. Asia Pacific Vaccines Revenue Market Share by Type (2016-2027)
    Figure 62. Asia Pacific Vaccines Sales Market Share by Application (2016-2027)
    Figure 63. Asia Pacific Vaccines Revenue Market Share by Application (2016-2027)
    Figure 64. Asia Pacific Vaccines Sales Share by Region (2016-2027)
    Figure 65. Asia Pacific Vaccines Revenue Share by Region (2016-2027)
    Figure 66. China Vaccines Revenue (2016-2027) & (US$ Million)
    Figure 67. Japan Vaccines Revenue (2016-2027) & (US$ Million)
    Figure 68. South Korea Vaccines Revenue (2016-2027) & (US$ Million)
    Figure 69. India Vaccines Revenue (2016-2027) & (US$ Million)
    Figure 70. Australia Vaccines Revenue (2016-2027) & (US$ Million)
    Figure 71. Taiwan Vaccines Revenue (2016-2027) & (US$ Million)
    Figure 72. Indonesia Vaccines Revenue (2016-2027) & (US$ Million)
    Figure 73. Thailand Vaccines Revenue (2016-2027) & (US$ Million)
    Figure 74. Malaysia Vaccines Revenue (2016-2027) & (US$ Million)
    Figure 75. Philippines Vaccines Revenue (2016-2027) & (US$ Million)
    Figure 76. Latin America Vaccines Sales Market Share by Type (2016-2027)
    Figure 77. Latin America Vaccines Revenue Market Share by Type (2016-2027)
    Figure 78. Latin America Vaccines Sales Market Share by Application (2016-2027)
    Figure 79. Latin America Vaccines Revenue Market Share by Application (2016-2027)
    Figure 80. Latin America Vaccines Sales Share by Country (2016-2027)
    Figure 81. Latin America Vaccines Revenue Share by Country (2016-2027)
    Figure 82. Mexico Vaccines Revenue (2016-2027) & (US$ Million)
    Figure 83. Brazil Vaccines Revenue (2016-2027) & (US$ Million)
    Figure 84. Argentina Vaccines Revenue (2016-2027) & (US$ Million)
    Figure 85. Middle East and Africa Vaccines Sales Market Share by Type (2016-2027)
    Figure 86. Middle East and Africa Vaccines Revenue Market Share by Type (2016-2027)
    Figure 87. Middle East and Africa Vaccines Sales Market Share by Application (2016-2027)
    Figure 88. Middle East and Africa Vaccines Revenue Market Share by Application (2016-2027)
    Figure 89. Middle East and Africa Vaccines Sales Share by Country (2016-2027)
    Figure 90. Middle East and Africa Vaccines Revenue Share by Country (2016-2027)
    Figure 91. Turkey Vaccines Revenue (2016-2027) & (US$ Million)
    Figure 92. Saudi Arabia Vaccines Revenue (2016-2027) & (US$ Million)
    Figure 93. U.A.E Vaccines Revenue (2016-2027) & (US$ Million)
    Figure 94. Vaccines Value Chain
    Figure 95. Vaccines Production Process
    Figure 96. Channels of Distribution
    Figure 97. Distributors Profiles
    Figure 98. Bottom-up and Top-down Approaches for This Report
    Figure 99. Data Triangulation
    Figure 100. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows multiple user to access the PDF.

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Strategic Venue Partners

RELATED REPORTS

Global Infectious Disease Diagnosis Market Size Status and Forecast 2021 2027
Global Infectious Disease Diagnosis Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-10N1843
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Infectious Disease Diagnostics Testing Market Size Status and Forecast 2021 2027
Global Infectious Disease Diagnostics Testing Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Othe-2O272
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global HPV Associated Disorder Market Size Status and Forecast 2021 2027
Global HPV Associated Disorder Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-28G2646
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Hepatitis B Treatment Market Size Status and Forecast 2021 2027
Global Hepatitis B Treatment Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-34S2647
Sun Jul 18 00:00:00 UTC 2021

Add to Cart